Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

West Nile Virus Exposure in Gezira State, Sudan: An ELISA-Based Study

Breadcrumb

  • Home
  • West Nile Virus Exposure In Gezira State, Sudan: An ELISA-Based Study
  • West Nile Virus Exposure in Gezira State, Sudan: An ELISA-Based Study

Sara Elsadig Elagib Eltahir *, Abd El Rahman Aldaw Mohammed and Omer Hassan Mohamed

Faculty of Medical Laboratory Sciences, University of Gezira, Sudan.
Research Article
GSC Biological and Pharmaceutical Sciences, 2025, 33(01), 280-286.
Article DOI: 10.30574/gscbps.2025.33.1.0407
DOI url: https://doi.org/10.30574/gscbps.2025.33.1.0407
Received on 14 September 2025; revised on 22 October 2025; accepted on 25 October 2025
West Nile Virus (WNV) is a mosquito-borne flavivirus responsible for West Nile fever. Although most infections are asymptomatic or mild, fewer than 1% progress to West Nile neuroinvasive disease (WNND), which has an estimated fatality rate of 10% (Petersen et al., 2013).
This cross-sectional study assessed WNV exposure among 400 residents of Gezira State, Sudan (2019–2022). Blood samples were collected and analyzed for WNV-specific IgG and IgM antibodies using ELISA, while RT-PCR was performed on IgG-positive samples to detect active viral RNA.
Overall, 62.3% (249/400) of participants were positive for WNV-IgG antibodies, indicating past exposure, whereas all samples were negative for WNV-IgM antibodies, suggesting the absence of recent infection. No significant correlations were observed between common risk factors and IgG positivity (P > 0.05), except for neck stiffness, which showed a significant association (P < 0.05).
The high prevalence of WNV-IgG antibodies, coupled with the absence of IgM positivity, highlights widespread prior exposure and a lack of current infection in the population. These findings underscore the need for sustained surveillance and public health initiatives focusing on mosquito control and community awareness to prevent future WNV outbreaks.
West Nile Virus; Igg Seroprevalence; Sudan; ELISA; Vector-Borne Disease
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2025-…

Preview Article PDF

Sara Elsadig Elagib Eltahir, Abd El Rahman Aldaw Mohammed and Omer Hassan Mohamed. West Nile Virus Exposure in Gezira State, Sudan: An ELISA-Based Study. GSC Biological and Pharmaceutical Sciences, 2025, 33(1), 280-286. Article DOI: https://doi.org/10.30574/gscbps.2025.33.1.0407


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution